Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice

Imipramine is a tricyclic antidepressant that has been approved for treating depression and anxiety in patients and animals and that has relatively mild side effects. However, the mechanisms of imipramine-associated disruption to metabolism and negative hepatic, renal, and retinal effects are not we...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Geng-Ruei, Hou, Po-Hsun, Wang, Chao-Min, Lin, Jen-Wei, Lin, Wei-Li, Lin, Tzu-Chun, Liao, Huei-Jyuan, Chan, Chee-Hong, Wang, Yu-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473438/
https://www.ncbi.nlm.nih.gov/pubmed/34564583
http://dx.doi.org/10.3390/vetsci8090189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473438/
https://www.ncbi.nlm.nih.gov/pubmed/34564583
http://dx.doi.org/10.3390/vetsci8090189

Ejemplares similares